Columnist Ben Hofmeister has just completed his third overnight sleep study in three years as part of an effort to control sleep apnea.
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q4 2025 Earnings Call Transcript February 11, 2026 Vanda Pharmaceuticals Inc. misses ...
14h
ORYZON Announces Appointment of Rolando Gutierrez-Esteinou, M.D., as Chief Medical Officer for CNS
Based in New Jersey (USA), to lead ORYZON’s CNS clinical development MADRID and CAMBRIDGE, Mass., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Oryzon ...
New clinical trial data suggest vidofludimus calcium can target key mechanisms underlying progressive multiple sclerosis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results